Prepregnancy Lipids Predict HDP Risk - Summary - MDSpire
From the Journals

Prepregnancy Lipids Predict HDP Risk

A large Swedish cohort found cardiometabolic biomarkers measured up to decades before pregnancy were associated with hypertensive disorders — with risk apparent even below standard diagnostic thresholds.

  • By

  • Andrea Surnit

  • May 5, 2026

  • 4 min

Share

Higher levels of cardiometabolic biomarkers measured years before pregnancy are linked to increased risks of hypertensive disorders of pregnancy (HDP) in a Swedish cohort study of 35,189 nulliparous women. Out of these, 1,938 women (5.5%) developed HDP, primarily preeclampsia. Key findings revealed lipid levels, especially apolipoprotein B, were significantly connected to HDP risk, while the associations for glucose and inflammation markers showed variability. The study indicates that assessing these biomarkers may enhance the identification of at-risk women, although it also emphasizes the observational nature of the findings and potential limitations in generalizability, as noted by lead researcher Angelika Qvick, MD.

Original Source(s)

Prepregnancy Lipids Predict HDP Risk

  • by Andrea Surnit

  • May 5, 2026

Related Content

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

Cervical Cancer Trends Differ by Age

Recent declines among women younger than 35 years contrasted with rising long-term incidence among women aged 35 to 49 years in Puerto Rico

Post-Dobbs Mortality Trends Remain Unclear

National cohort shows smaller mortality declines in ban states and divergent patterns by race and geography.